STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS

乌白眉猴自然 SIV 感染的研究

基本信息

  • 批准号:
    8884717
  • 负责人:
  • 金额:
    $ 81.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-03-01 至 2021-02-28
  • 项目状态:
    已结题

项目摘要

Abstract: This proposal and progress report are intended to continue the work started in R37 AI066998. In the next funding cycle, we plan to expand this work in three broad areas that are outlined below. Area #1. To define the molecular mechanisms responsible for the differences in the pattern of infected cells between SIV-infected SMs and SIV-infected macaques and/or HIV-infected humans. Area #2. To characterize the relationship between the specific pattern of infected cells observed in SIV- infected SMs and their ability to avoid the chronic Immune activation of pathogenic HIV/SIV infections. Area #3. To determine how the SM-specific pattern of infected cells results in different features of the virus reservoir under anti-retroviral therapy (ART). We believe that these studies will advance significantly our understanding of how naturally SIV-infected SMs are resistant to AIDS despite high viremia. We envision that answering this question will provide clues to AIDS pathogenesis in humans that will have ultimately an impact on the prevention and treatment of HIV infection. RELEVANCE (See instructions): Sooty mangabeys do not progress to AIDS despite being naturally infected with SIV, a virus closely related to HIV. The proposed studies are aimed at understanding why the sooty mangabeys are able to remain healthy when infected with SIV. We believe that these studies will improve our comprehension of AIDS pathogenesis in humans and that this knowledge will ultimately translate in better prevention and therapies fnr thfi infection
文摘:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guido Silvestri其他文献

Guido Silvestri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guido Silvestri', 18)}}的其他基金

Core B_Silvestri
核心B_Silvestri
  • 批准号:
    10339441
  • 财政年份:
    2021
  • 资助金额:
    $ 81.36万
  • 项目类别:
Core 1: Non-human primate core
核心1:非人类灵长类核心
  • 批准号:
    10194350
  • 财政年份:
    2017
  • 资助金额:
    $ 81.36万
  • 项目类别:
Core 1: Non-human primate core
核心1:非人类灵长类核心
  • 批准号:
    10360195
  • 财政年份:
    2017
  • 资助金额:
    $ 81.36万
  • 项目类别:
Project 3- Mucosal Determinants of Virus Transmission
项目3-病毒传播的粘膜决定因素
  • 批准号:
    9141194
  • 财政年份:
    2016
  • 资助金额:
    $ 81.36万
  • 项目类别:
Antiviral role of CD8+T cells in ART-treated SIV-infected macaques
CD8 T 细胞在 ART 治疗的 SIV 感染猕猴中的抗病毒作用
  • 批准号:
    10378680
  • 财政年份:
    2016
  • 资助金额:
    $ 81.36万
  • 项目类别:
Antiviral role of CD8+T cells in ART-treated SIV-infected macaques
CD8 T 细胞在 ART 治疗的 SIV 感染猕猴中的抗病毒作用
  • 批准号:
    10258652
  • 财政年份:
    2016
  • 资助金额:
    $ 81.36万
  • 项目类别:
Antiviral role of CD8+T cells in ART-treated SIV-infected macaques
CD8 T 细胞在 ART 治疗的 SIV 感染猕猴中的抗病毒作用
  • 批准号:
    10593104
  • 财政年份:
    2016
  • 资助金额:
    $ 81.36万
  • 项目类别:
Targeting SIV reservoirs with type I Interferons
使用 I 型干扰素靶向 SIV 病毒库
  • 批准号:
    8842384
  • 财政年份:
    2014
  • 资助金额:
    $ 81.36万
  • 项目类别:
Targeting SIV reservoirs with type I Interferons
使用 I 型干扰素靶向 SIV 病毒库
  • 批准号:
    8930061
  • 财政年份:
    2014
  • 资助金额:
    $ 81.36万
  • 项目类别:
Transcriptome resources for comparative primate models of lentivirus infection
慢病毒感染比较灵长类动物模型的转录组资源
  • 批准号:
    8714090
  • 财政年份:
    2013
  • 资助金额:
    $ 81.36万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 81.36万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 81.36万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 81.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 81.36万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 81.36万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 81.36万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 81.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 81.36万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 81.36万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 81.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了